SOUTH SAN FRANCISCO, Calif., Jan. 15, 2016 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA) today announced the appointment of Kelly Bryant as senior director, business development based in CLSA's South San Francisco office. Bryant is responsible for designing and delivering the best in class member experience that CLSA members have come to expect. Bryant will spearhead member development programs and serves as the Bay Area's trusted resource for maximizing CLSA's membership privileges. As the nation's largest statewide life sciences public policy, advocacy and business solutions organization, CLSA serves over 750 life sciences organizations across California.
Bryant will play a key role in business development and forging partnerships throughout the state, while implementing strategic programs that produce premium member value. Additionally, Bryant will serve as an ambassador for CLSA, building industry wide awareness of the CLSA member experience.
"As CLSA continues to grow and support California's life sciences economy and community, we sought an industry veteran to help meet and exceed the member goals and business objectives of our organization," said CLSA President and CEO Sara Radcliffe. "Given Kelly's extensive background and leadership qualities, CLSA members will greatly benefit from this dynamic asset."
Bryant's track record spans from the medical device, technical genomic and health sciences sectors including stints at Ceres, MDVIP (a Proctor & Gamble Co.), and Boston Scientific.
"Kelly embodies exactly what CLSA members expect when they join the most prestigious network of life sciences pioneers, risk takers and thought leaders," said Holly Smithson, Senior Vice President, Business Strategy and Development. "Kelly is a dynamic professional and committed to brokering member successes at all levels. I expect CLSA members may well enjoy her X factor."
Headshot available upon request.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Contact:
Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848


Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Shell M&A Chief Exits After BP Takeover Proposal Rejected
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 



